Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT2031230393Active, not recruiting
Trial of flurbiprofen (2 arms), sponsored by Lead Chemical. Primary endpoint: Amount of flurbiprofen in the stratum corneum. Started Oct 2023; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT2031230393.